Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
CareTalk with Laura Packard: Big Pharma Loses Again! But Will Trump's Deals Lower Your Drug Prices?
Big Pharma just lost again in court, but will your drug prices actually go down? On this episode of #CareTalk, I’m joined by Merith Basey from @patientsforaffordabledrugs for an update on the Medicare drug price negotiation lawsuits, Trump’s Most Favored Nation deals with drug manufacturers, and what it all means for patients. A federal appeals […]
Press Releases
ICYMI: The Price Patients Pay — How High Drug Prices Shape Hispanic and Latino Families' Lives
New report documents how high drug prices shape the lives of Hispanic and Latino families WASHINGTON, D.C. — Last week, Patients For Affordable Drugs released The Price Patients Pay: How Unaffordable Prescription Drugs Shape the Health, Finances, and Daily Lives of Hispanic and Latino Communities alongside We Are Más and Brown University’s Information Futures Lab — a report […]
News and Reports
Washington Post Health Brief: Health Brief: Health care’s December pileup
“Patients need systemic reforms that will lower drug prices, rather than short-term, voluntary agreements whose terms remain secret,” said Merith Basey, CEO of advocacy group Patients For Affordable Drugs. The deals announced on Monday, Basey added, “focus on Medicaid, where steep discounts already exist, and even then, states can choose whether to participate.”
Press Releases
NEW REPORT: How High Prescription Drug Prices Shape the Lives of Hispanic and Latino Families
WASHINGTON, D.C. — Hispanic and Latino patients are delaying treatment, rationing medication, taking on debt, and traveling abroad to purchase prescription drugs because they cannot afford the high prices charged in the United States, according to a new report released today by Patients For Affordable Drugs, We Are Más, and Brown University’s Information Futures Lab. […]
News and Reports
Common Dreams: Trump Pharma Deals Called Distraction From ‘Failed Plan to Lower US Drug Prices’
Like Public Citizen, the advocacy group Patients for Affordable Drugs was critical of the new deals, with CEO Merith Basey pointing out that “for decades, drug companies have been charging Americans at least four times more for brand-name medicines than people in other high-income nations.” “Patients need systemic reforms that will lower drug prices, rather […]